TGFβ1 induces resistance of human lung myofibroblasts to cell death via down‐regulation of TRPA1 channels. (25th May 2021)
- Record Type:
- Journal Article
- Title:
- TGFβ1 induces resistance of human lung myofibroblasts to cell death via down‐regulation of TRPA1 channels. (25th May 2021)
- Main Title:
- TGFβ1 induces resistance of human lung myofibroblasts to cell death via down‐regulation of TRPA1 channels
- Authors:
- Virk, Harvinder S.
Biddle, Michael S.
Smallwood, Dawn T.
Weston, Cathryn A.
Castells, Emily
Bowman, Viona W.
McCarthy, Jamie
Amrani, Yassine
Duffy, S. Mark
Bradding, Peter
Roach, Katy M. - Abstract:
- Abstract : Background and Purpose: TGFβ1‐mediated myofibroblast activation contributes to pathological fibrosis in many diseases including idiopathic pulmonary fibrosis (IPF), where myofibroblast resistance to oxidant‐mediated apoptosis is also evident. We therefore investigated the involvement of redox‐sensitive TRPA1 ion channels on human lung myofibroblasts (HLMFs) cell death and TGFβ1‐mediated pro‐fibrotic responses. Experimental approach: The effects of TGFβ1 stimulation on TRPA1 expression and cell viability was studied in HLMFs derived from IPF patients and non‐fibrotic patients. We also examined a model of TGFβ1‐dependent fibrogenesis in human lung. We used qRT‐PCR, immunofluorescent assays, overexpression with lentiviral vectors and electrophysiological methods. Key Results: TRPA1 mRNA, protein and ion currents were expressed in HLMFs derived from both non‐fibrotic patient controls and IPF patients, and expression was reduced by TGFβ1. TRPA1 mRNA was also down‐regulated by TGFβ1 in a model of lung fibrogenesis in human lung. TRPA1 over‐expression or activation induced HLMF apoptosis, and activation of TRPA1 channel activation by H2 O2 induced necrosis. TRPA1 inhibition following TGFβ1 down‐regulation or pharmacological inhibition, protected HLMFs from both apoptosis and necrosis. Lentiviral vector mediated TRPA1 expression was also found to induce sensitivity to H2 O2 induced cell death in a TRPA1‐negative HEK293T cell line. Conclusion and Implications: TGFβ1Abstract : Background and Purpose: TGFβ1‐mediated myofibroblast activation contributes to pathological fibrosis in many diseases including idiopathic pulmonary fibrosis (IPF), where myofibroblast resistance to oxidant‐mediated apoptosis is also evident. We therefore investigated the involvement of redox‐sensitive TRPA1 ion channels on human lung myofibroblasts (HLMFs) cell death and TGFβ1‐mediated pro‐fibrotic responses. Experimental approach: The effects of TGFβ1 stimulation on TRPA1 expression and cell viability was studied in HLMFs derived from IPF patients and non‐fibrotic patients. We also examined a model of TGFβ1‐dependent fibrogenesis in human lung. We used qRT‐PCR, immunofluorescent assays, overexpression with lentiviral vectors and electrophysiological methods. Key Results: TRPA1 mRNA, protein and ion currents were expressed in HLMFs derived from both non‐fibrotic patient controls and IPF patients, and expression was reduced by TGFβ1. TRPA1 mRNA was also down‐regulated by TGFβ1 in a model of lung fibrogenesis in human lung. TRPA1 over‐expression or activation induced HLMF apoptosis, and activation of TRPA1 channel activation by H2 O2 induced necrosis. TRPA1 inhibition following TGFβ1 down‐regulation or pharmacological inhibition, protected HLMFs from both apoptosis and necrosis. Lentiviral vector mediated TRPA1 expression was also found to induce sensitivity to H2 O2 induced cell death in a TRPA1‐negative HEK293T cell line. Conclusion and Implications: TGFβ1 induces resistance of HLMFs to TRPA1 agonist‐ and H2 O2 ‐mediated cell death via down‐regulation of TRPA1 channels. Our data suggest that therapeutic strategies which prevent TGFβ1‐dependent down‐regulation of TRPA1 may reduce myofibroblast survival in IPF and therefore improve clinical outcomes. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 178:Number 15(2021)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 178:Number 15(2021)
- Issue Display:
- Volume 178, Issue 15 (2021)
- Year:
- 2021
- Volume:
- 178
- Issue:
- 15
- Issue Sort Value:
- 2021-0178-0015-0000
- Page Start:
- 2948
- Page End:
- 2962
- Publication Date:
- 2021-05-25
- Subjects:
- apoptosis -- fibrosis -- IPF -- myofibroblast -- oxidative stress -- TGFβ1 -- TRPA1
Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.15467 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17584.xml